In Vitro Diagnostics (POC/Rapid diagnostics) Global market - Forecast to 2020


Posted March 27, 2017 by Shirley

MarketResearchReportStore adds "In Vitro Diagnostics (POC/Rapid diagnostics) Global market - Forecast to 2020" latest studies, published in February 2017. It is a professional and in-depth study.

 
"In Vitro Diagnostics (POC/Rapid diagnostics) Global market - Forecast to 2020 by Market Research Report Store", for this report sample, please email at: [email protected]

MarketResearchReportStore adds "In Vitro Diagnostics (POC/Rapid diagnostics) Global market - Forecast to 2020" latest studies, published in February 2017. It is a professional and in-depth study.

This research report will help you understand, formulate and implement strategic decisions, by offering critical data, insights and analysis on the In Vitro Diagnostics (POC/Rapid diagnostics) Market.

Description
In vitro diagnostics are tests that diagnose and prevent diseases, conditions or infections. IVD tests are performed outside body in an artificial environment on samples such as blood, urine, tissue isolated from human body. IVD is classified into 3 types namely: clinical laboratory testing, near-patient testing, self-testing. IVD market is segmented by-techniques (including immunoassays, point of care, molecular diagnostics, hematology, coagulation, microbiology, clinical techniques, microbiology), product-type (including instruments, reagents, services, data management systems), usability (including disposable, reusable), applications (including diabetes, oncology, cardiology, HIV/AIDS, autoimmune disease, nephrology, drug testing), -end-user (including hospitals, laboratories, academics) and geography (globally).
The global IVD market was reported with high revenue in previous years and hence expected to grow at a high CAGR by 2019. The Asia-Pacific and RoW regions are expected to register a significant growth rate for the IVD market. North America commands the largest share while Asia Pacific is the fastest revenue growing region.
IVD market growth is driven by factors such as increase in incidences of chronic and infectious diseases across all age cohorts, genetic diseases, aging population, rising acceptance of personalized medicine, rise in healthcare awareness in patients and high unmet medical needs in diagnosing diseases. Screening initiatives and high investment in healthcare infrastructures mainly contributes to market growth. Whereas, difficulty in rendering rapid diagnostic results, stringent regulatory policies, reimbursement issues and economic crisis are the major growth restraints. Different geographies is an opportunistic factor which improved IVD market growth.
Roche diagnostics (Basel, Switzerland) is expected to be the largest player in the IVD market, followed by Siemens and Abbott. The IVD market is highly consolidated, with the major players holding close to 80% market share. Top ten major players are Roche Diagnostics, Siemens Healthcare(Erlangen, Germany), Abbott(Abbott Park, Illinois), Johnson and Johnson(New Jersey), Beckman Coulter(Massachusetts), Becton Dickinson(U.S.), bioMerieux (France), Bayer Diabetes(Germany), Sysmex (U.S.) and Bio-Rad(California). Key players such as Thermo Fisher Scientific, Inc., QIAGEN N.V., and ARKRAY, Inc. have established new manufacturing facilities and R&D units in China to grow IVD market.
The focus of this research report description was on various levels of analysis, industry, market shares, value chain, PESTEL analysis and company profiles which together comprise and augment about competitive landscape, emerging and high growth segments of in vitro diagnostic (molecular diagnostics & point of care testing), emerging technologies.

The report provides an in depth market analysis of the above mentioned segments across the following regions:
• North America
• Europe
• Asia-Pacific
• Rest of the World (RoW)

Request Sample Copy, please email at: [email protected]

Table Of Contents
3. Market Analysis.
3.1. Introduction.
3.2. Market Segmentation.
3.3. Factors Influencing Market.
3.3.1. Drivers And Opportunities.
3.3.1.1. Aged Cohort With Increased Incidence Of Chronic And Infectious Diseases And Implementation Of Minimal Invasive Technology.
3.3.1.2. Point-Of-Care Testing (Poct) And Its Technological Advancements.
3.3.1.3. Prevalence Of Personalized Medicine Approach.
3.3.1.4. Cost-Effectiveness.
3.3.1.5. Healthcare Awareness And Government Funding.
3.3.1.6. Extending Reach Of Molecular Diagnostics.
3.3.1.7. Commercial Trends For Development Of Condition-Specific Markers In Ivd Tests.
3.3.1.8. Biothreat Warfare Agents Posing An Opportunity.
3.3.2. Restraints And Threats.
3.3.2.1. Affordability Of Healthcare Diagnostics.
3.3.2.2. Intensified Competition.
3.3.2.3. Reimbursement Issues.
3.3.2.4. Stringent Regulatory Framework:.
3.3.2.5. Medical Device Excise Tax:.
3.3.3. Problem Areas.
3.3.3.1. Laboratory Automation For Increased Efficiency And Accurate Diagnosis:.
3.3.4. Winning Imperative.
3.3.4.1. Non-Proprietary System With Enhanced Functionalities.
3.4. Regulatory Affairs.
3.4.1. U.S..
3.4.2. Europe.
3.4.3. China.
3.4.4. India.
3.4.5. Japan.
3.5. Porter’S Five Force Analysis.
3.5.1. Threat Of New Entrants.
3.5.2. Threat Of Substitutes.
3.5.3. Rivalry Among Existing Competitors.
3.5.4. Bargaining Power Of Suppliers.
3.5.5. Bargaining Power Of Buyers.
3.6. Supply Chain Analysis.
3.7. Market Share Analysis By Major Players.

List of Tables and Figures
TABLE 1 IVD INSTRUMENTS & REAGENTS GLOBAL MARKET REVENUE, BY GEOGRAPHY, (2012-2020) ($BN)
TABLE 2 IVD INSTRUMENTS & REAGENTS GLOBAL MARKET REVENUE, BY TECHNIQUE, (2012-2020) ($BN)
TABLE 3 IVD INSTRUMENTS & REAGENTS GLOBAL MARKET REVENUE, BY TECHNIQUE, (2012-2020) ($BN)
TABLE 4 IVD INSTRUMENTS & REAGENTS IMMUNOLOGY MARKET REVENUE, BY GEOGRAPHY, (2012-2020) ($BN)
TABLE 5 IVD INSTRUMENTS & REAGENTS HEMATOLOGY MARKET REVENUE, BY GEOGRAPHY, (2012-2020) ($BN)
TABLE 6 IVD INSTRUMENTS & REAGENTS CLINICAL CHEMISTRY MARKET REVENUE, BY GEOGRAPHY, (2012-2020) ($BN)
TABLE 7 IVD INSTRUMENTS & REAGENTS MOLECULAR DIAGNOSTICS MARKET REVENUE, BY GEOGRAPHY, (2012-2020) ($BN)
TABLE 8 IVD INSTRUMENTS & REAGENTS COAGULATION MARKET REVENUE, BY GEOGRAPHY, (2012-2020) ($BN)
TABLE 9 IVD INSTRUMENTS & REAGENTS MICROBIOLOGY MARKET REVENUE, BY GEOGRAPHY, (2012-2020) ($BN)
TABLE 10 IVD INSTRUMENTS & REAGENTS OTHER CLINICAL INSTRUMENTS MARKET REVENUE, BY GEOGRAPHY, (2012-2020) ($BN)
TABLE 11 IVD INSTRUMENTS & REAGENTS GLOBAL MARKET REVENUE, BY PRODUCTS (2012-2020) ($BN)
...

Browse Complete Report with TOC @
https://www.marketresearchreportstore.com/shop/in-vitro-diagnostics-pocrapid-diagnostics-global-market-forecast-to-2020-7

For report sample or more information, please feel free to contact us:
Shirley | Sales Director
Call: +00-1-626-3463946 - U.S
Email: [email protected]
Web: http://www.marketresearchreportstore.com/

About Market Research Report Store ( MRRS )
Market Research Report Store (MRRS) is a market research report sales website that works with many of the world’s largest market report publishers,we provide a variety of market report to our customers who from US,Germany,UK,Russia,Japan, Korea,India,Italy,China etc.
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Market Research Report Store
Country United States
Categories Business , Marketing , Reports
Last Updated March 27, 2017